SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-016901
Filing Date
2020-01-28
Accepted
2020-01-28 16:01:05
Documents
1
Effectiveness Date
2020-01-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d875215ddefa14a.htm DEFA14A 28986
  Complete submission text file 0001193125-20-016901.txt   30117
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36621 | Film No.: 20554224
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences